Human Microbiome Market Size [+Key Analysis] | Share & Global Report Revenue | 4D pharma plc, BIOHM , BiomX

According to the latest report by IMARC Group, titled "Human Microbiome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global human microbiome market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 18% during 2021-2026.

Industry Overview and Application:

The human microbiome represents the genes present within the microorganisms found in the genetic portrait or metagenome of humans. It comprises numerous microorganisms, such as bacteria, protozoa, fungi, non-living viruses, single-celled organisms, etc., which impact human physiology and promote the enhancement or impairment of immune and metabolic functions. They are found in human tissues and are studied for various medical advancements and analytical techniques. Microbiomes are utilized in prebiotics, probiotics, pharmaceutical drugs, diagnostic and therapeutic systems, etc., for different ailments, including diabetes, obesity, cancer, etc., and disorders such as metabolic, neurological, gastrointestinal, central nervous system, autoimmune, etc.

Note: We are updating our reports, If you want the latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.

Download Free Sample of the Report: https://www.imarcgroup.com/human-microbiome-market/requestsample

Market Trends and Drivers:

• The growing incidences of infections and chronic lifestyle diseases across the globe owing to microbial dysbiosis are among the key factors driving the human microbiome market.

• Moreover, the expanding geriatric population, who are more susceptible to such ailments, is further propelling the product demand. In addition to this, the elevating focus on developing human microbiome therapeutics with enhanced efficacy is acting as another growth-inducing factor.

• Furthermore, the sudden onset of the COVID-19 pandemic is also bolstering the market growth since researchers are extensively studying the lung microbiomes to determine the severity of the infections and to produce appropriate therapeutics and vaccines.

• Besides this, various advancements in target-specific microbiome-based therapies are anticipated to fuel the human microbiome market over the forecasted period.

Competitive Landscape with Key Players:

• 4D pharma plc
• Atlas Biomed Group Limited
• BIOHM
• BiomX
• Bione
• DayTwo Inc.
• ENTEROME
• Ferring B.V.
• Finch Therapeutics
• Second Genome Inc.
• SynBioBeta LLC
• Synthetic Biologics Inc.
• Vedanta Biosciences Inc.
• Viome Inc.

Inquire Before Buying: https://www.imarcgroup.com/request?type=report&id=4420&flag=F

Key Highlights of the Market Segmentation:
The report has segmented the global human microbiome market on the basis of product, application, disease type and region.

Breakup by Product:

• Probiotics
• Prebiotics
• Diagnostic Tests
• Drugs
• Medical Food
• Others

Breakup by Application:

• Therapeutics
• Diagnostics

Breakup by Disease Type:

• Obesity
• Diabetes
• Autoimmune Disorders
• Cancer
• Gastrointestinal Disorders
• Central Nervous System Disorders
• Others

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/human-microbiome-market

TOC for the Human Microbiome Market Research Report:

Preface
Scope and Methodology
Executive Summary
Introduction
Global Human Microbiome Market
SWOT Analysis
Value Chain Analysis
Price Analysis
Competitive Landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Glucaric Acid Market: https://www.marketwatch.com/press-release/glucaric-acid-market-growth-statistics-size-estimation-emerging-trends-outlook-to-2027-2022-08-16

eHealth Market: https://www.marketwatch.com/press-release/ehealth-market-analysis-by-capital-investment-industry-outlook-growth-potential-opportunities-trends-2022-08-11

industrial Microbiology Market: https://www.marketwatch.com/press-release/radio-advertising-market-top-companies-analysis-in-depth-insight-business-opportunities-and-forecast-2027-2022-08-10

Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.

This release was published on openPR.